All companies
Visit website
TURN THERAPEUTICS
PublicGlobal Health Solutions, Inc.
Healthcare · Founded 2015
Revolution in advanced wound & dermatology care
Post-money valuation ⓘ
$163.0M
As of Jun 2025 · from Reg A Offering (2025) · pre-money + amount raised, not a traded price
Total raised
$2,296,843
Across 3 rounds since 2024
Latest share price
$11.26
Reg A Offering (2025) offering price
Financials
FY2022–FY2025 · from SEC filings · hover any figure for its source$0
−$4.3M
2022
$0
−$3.1M
2023
$0
−$1.8M
2024
−$3.2M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
$0
—
Cost of goods sold
$0
$0
$0
—
Net income
-$4,286,851
-$3,065,349
-$1,768,415
-$3,194,080
Taxes paid
$0
$0
$0
—
Balance sheet
Cash
$2,102,983
$1,180,997
$498,286
$4,027,862
Accounts receivable
$0
$0
$0
—
Total assets
$2,913,411
$2,012,504
$2,048,889
$12,162,241
Short-term debt
$1,724,014
$0
$0
—
Long-term debt
$34,203
$0
$0
—
Total liabilities
$1,758,217
$1,869,225
$2,226,321
$7,475,518
Other
Headcount
—
1
4
—
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$123.5M
post-money
$125.9M
post-money
$163.0M
post-money
Turn Therapeutics Common Stock 1
Turn Therapeutics Common Stock 2
Reg A Offering (2025)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $438.5K / $18.1MInvestors 127Post-money $163M
Raised $955.5K / $4.1MInvestors 700Post-money $125.9M
Reg CF annual-report compliance
Not requiredBecame a public company
Filed 1 of 2 annual reports (FY2024–FY2025)
700 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 25 filings on EDGARSource: ManualCIK 0002023016Share price $11.26
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.